Indication:

For prevention of vascular ischaemia associated with atherothrombotic events (myocardial infarction, stroke and vascular death) in patients with a history of symptomatic atherosclerotic disease. ,Acute Coronary Syndrome: Clopidogrel Tablets is indicated in combination with aspirin for patients with: ,- Unstable angina or non-ST-elevation myocardial infarction in order to prevent early and long-term atherothrombotic events (myocardial infarction, stroke, vascular death or refractory ischaemia). Clopidogrel Tablets is indicated for the treatment of acute coronary syndrome whether or not patients undergo cardiac revascularization (surgical or PCI, with or without stent); ,- ST-segment elevation acute myocardial infarction in order to prevent atherothrombotic events. In this population, Clopidogrel has been shown to reduce the rate of death from any cause and the rate of a combined endpoint of death, re-infarction or stroke in medically treated patients eligible for thrombolytic therapy.

Generic Name: Clopidogrel

Strength: 75mg

Dosage: Tabs

Shelflife Months: 36

Pack Size: 28

Tablet Description: Pink coloured, round, biconvex, film coated tablets, debossed with 'Cl' on one side and plain on other side

Segment :B

Innovator: Plavix®

PBSListed: Yes

RPBSlisted: Yes

Schedule: S4

Storage Conditions:
Store below 25 degrees Celsius

Active Ingredients: clopidogrel hydrogen sulfate 97.875mg
Equivalent: clopidogrel 75mg

Warnings: